These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3466334)

  • 1. HLA antigens and gold toxicity in American blacks with rheumatoid arthritis.
    Alarcón GS; Barger BO; Acton RT; Koopman WJ
    Rheumatol Int; 1986; 6(1):13-7. PubMed ID: 3466334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens and seronegative rheumatoid arthritis.
    Bardin T; Legrand L; Naveau B; Marcelli-Barge A; Debeyre N; Lathrop GM; Poirier JC; Schmid M; Ryckewaert A; Dryll A
    Ann Rheum Dis; 1985 Jan; 44(1):50-3. PubMed ID: 3855618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA.
    Singal DP; Green D; Reid B; Gladman DD; Buchanan WW
    Ann Rheum Dis; 1992 Jan; 51(1):23-8. PubMed ID: 1371662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of rheumatoid arthritis with HLA in three South African populations--whites, blacks and a population of mixed ancestry.
    Martell RW; du Toit ED; Kalla AA; Meyers OL
    S Afr Med J; 1989 Sep; 76(5):189-90. PubMed ID: 2772763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of HLA phenotypes on the response to parenteral gold in rheumatoid arthritis.
    Speerstra F; van Riel PL; Reekers P; van de Putte LB; Vandenbroucke JP
    Tissue Antigens; 1986 Jul; 28(1):1-7. PubMed ID: 3092399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.
    Tishler M; Caspi D; Gazit E; Yaron M
    Ann Rheum Dis; 1988 Mar; 47(3):215-7. PubMed ID: 2965554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA associations in aurothioglucose- and D-penicillamine-induced haematotoxic reactions in rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP
    Tissue Antigens; 1985 Jul; 26(1):35-40. PubMed ID: 3929421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens.
    Ferraccioli G; Peri F; Nervetti A; Ambanelli U; Savi M
    J Rheumatol; 1986 Feb; 13(1):65-8. PubMed ID: 3084782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cross reactions of HLA A and B antigens in 63 patients with rheumatoid arthritis].
    Dreyfus P; Geay D; Cambon H; Daupleix D
    Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):197-202. PubMed ID: 6587517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and associations of HLA-DR and HLA-DQ antigens in a British Caucasoid panel.
    Awad J; Navarrete C; Festenstein H
    Tissue Antigens; 1987 Jan; 29(1):55-9. PubMed ID: 3473746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DR antigens and gold toxicity in white rheumatoid arthritis patients.
    Barger BO; Acton RT; Koopman WJ; Alarcón GS
    Arthritis Rheum; 1984 Jun; 27(6):601-5. PubMed ID: 6587852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis.
    Bardin T; Dryll A; Debeyre N; Ryckewaert A; Legrand L; Marcelli A; Dausset J
    Ann Rheum Dis; 1982 Dec; 41(6):599-601. PubMed ID: 6959574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
    Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
    J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seronegative rheumatoid arthritis and HLA-DR4.
    al-Jarallah KF; Buchanan WW; Sastry A; Singal DP
    J Rheumatol; 1994 Feb; 21(2):190-3. PubMed ID: 8182622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histocompatibility antigens (A, B, C, and DR) in Arabs with rheumatoid arthritis.
    Sattar MA; al-Saffar M; Guindi RT; Sugathan TN; White AG; Behbehani K
    Dis Markers; 1990; 8(1):11-5. PubMed ID: 2311344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA and disease manifestations in rheumatoid arthritis--a Canadian experience.
    Gladman DD; Anhorn KA
    J Rheumatol; 1986 Apr; 13(2):274-6. PubMed ID: 3459890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HLA-DRw4 with rheumatoid arthritis in black and white patients.
    Karr RW; Rodey GE; Lee T; Schwartz BD
    Arthritis Rheum; 1980 Nov; 23(11):1241-5. PubMed ID: 6934774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.